These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
255 related items for PubMed ID: 17698058
1. Osteoblast protects osteoclast devoid of sodium-dependent vitamin C transporters from oxidative cytotoxicity of ascorbic acid. Takarada T, Hinoi E, Kambe Y, Sahara K, Kurokawa S, Takahata Y, Yoneda Y. Eur J Pharmacol; 2007 Dec 01; 575(1-3):1-11. PubMed ID: 17698058 [Abstract] [Full Text] [Related]
2. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro]. Xiao XH, Zhou HD, Yuan LQ, Xie H, Liao EY. Zhonghua Yi Xue Za Zhi; 2004 Dec 17; 84(24):2102-6. PubMed ID: 15730627 [Abstract] [Full Text] [Related]
3. Direct inhibitory and indirect stimulatory effects of RAGE ligand S100 on sRANKL-induced osteoclastogenesis. Yoshida T, Flegler A, Kozlov A, Stern PH. J Cell Biochem; 2009 Aug 01; 107(5):917-25. PubMed ID: 19415676 [Abstract] [Full Text] [Related]
4. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation. Wang X, Wu J, Shidoji Y, Muto Y, Ohishi N, Yagi K, Ikegami S, Shinki T, Udagawa N, Suda T, Ishimi Y. J Bone Miner Res; 2002 Jan 01; 17(1):91-100. PubMed ID: 11771673 [Abstract] [Full Text] [Related]
7. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation. Häusler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT. J Bone Miner Res; 2004 Nov 01; 19(11):1873-81. PubMed ID: 15476588 [Abstract] [Full Text] [Related]
8. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells. Koh JM, Lee YS, Byun CH, Chang EJ, Kim H, Kim YH, Kim HH, Kim GS. J Endocrinol; 2005 Jun 01; 185(3):401-13. PubMed ID: 15930166 [Abstract] [Full Text] [Related]
10. Vitamin C intake inhibits serum lipid peroxidation and osteoclast differentiation on alveolar bone in rats fed on a high-cholesterol diet. Sanbe T, Tomofuji T, Ekuni D, Azuma T, Irie K, Tamaki N, Yamamoto T, Morita M. Arch Oral Biol; 2009 Mar 01; 54(3):235-40. PubMed ID: 19110235 [Abstract] [Full Text] [Related]
11. Beta-glycerophosphate accelerates RANKL-induced osteoclast formation in the presence of ascorbic acid. Noh AL, Yim M. Pharmazie; 2011 Mar 01; 66(3):195-200. PubMed ID: 21553650 [Abstract] [Full Text] [Related]
12. Osteoclastogenesis is decreased by cysteine proteinase inhibitors. Brage M, Lie A, Ransjö M, Kasprzykowski F, Kasprzykowska R, Abrahamson M, Grubb A, Lerner UH. Bone; 2004 Mar 01; 34(3):412-24. PubMed ID: 15003789 [Abstract] [Full Text] [Related]
13. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ. J Bone Miner Res; 2000 Aug 01; 15(8):1459-66. PubMed ID: 10934644 [Abstract] [Full Text] [Related]
14. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha. Kim HJ, Chang EJ, Kim HM, Lee SB, Kim HD, Su Kim G, Kim HH. Free Radic Biol Med; 2006 May 01; 40(9):1483-93. PubMed ID: 16632109 [Abstract] [Full Text] [Related]
15. Oral administration of phenolic antidiarrheic ingredients prevents ovariectomy-induced bone loss. Moriguchi N, Hinoi E, Takarada T, Matsushima N, Uno K, Yoneda Y. Biochem Pharmacol; 2007 Feb 01; 73(3):385-93. PubMed ID: 17078932 [Abstract] [Full Text] [Related]
16. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors. Itoh K, Udagawa N, Matsuzaki K, Takami M, Amano H, Shinki T, Ueno Y, Takahashi N, Suda T. J Bone Miner Res; 2000 Sep 01; 15(9):1766-75. PubMed ID: 10976996 [Abstract] [Full Text] [Related]
17. Inhibition of osteoclast differentiation by polycyclic aryl hydrocarbons is dependent on cell density and RANKL concentration. Voronov I, Heersche JN, Casper RF, Tenenbaum HC, Manolson MF. Biochem Pharmacol; 2005 Jul 15; 70(2):300-7. PubMed ID: 15919055 [Abstract] [Full Text] [Related]
18. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms. O'Sullivan S, Naot D, Callon K, Porteous F, Horne A, Wattie D, Watson M, Cornish J, Browett P, Grey A. J Bone Miner Res; 2007 Nov 15; 22(11):1679-89. PubMed ID: 17663639 [Abstract] [Full Text] [Related]
19. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal. Lee JH, Jin H, Shim HE, Kim HN, Ha H, Lee ZH. Mol Pharmacol; 2010 Jan 15; 77(1):17-25. PubMed ID: 19828731 [Abstract] [Full Text] [Related]
20. Protective effects of estradiol on ethanol-induced bone loss involve inhibition of reactive oxygen species generation in osteoblasts and downstream activation of the extracellular signal-regulated kinase/signal transducer and activator of transcription 3/receptor activator of nuclear factor-kappaB ligand signaling cascade. Chen JR, Shankar K, Nagarajan S, Badger TM, Ronis MJ. J Pharmacol Exp Ther; 2008 Jan 15; 324(1):50-9. PubMed ID: 17916759 [Abstract] [Full Text] [Related] Page: [Next] [New Search]